Magnes is a global medical technology company spun out of ETH Zurich and headquartered in Switzerland. We develop intelligent wearable solutions using AI and embedded sensors to analyze movement and deliver real-time vibrotactile feedback. Our flagship product, NUSHU, is a smart shoe for people with neurological and movement disorders. It supports objective gait assessment, greater stability, and personalized rehabilitation in collaboration with clinicians and research partners worldwide.

Personalised medicine depends on timely genetic information, but current genetic testing workflows are often too slow for time-sensitive clinical decisions. We are providing necessary genetic information to realise personalised medicine.

REM Analytics is a Swiss diagnostics company in Monthey, Valais. Its ATGC platform, built on Cycling Temperature Capillary Electrophoresis, measures the microbiome with the reliability of a routine diagnostic test and resolves closely related organisms down to strain level. REM sells assay panels (its vaginal-microbiome test is CE-marked as an IVD), the Cello instrument that runs them, and assay-development and testing services to partners in health, nutrition and fermentation.

Synendos is a Phase 2 clinical stage neuroscience company developing safe and effective therapies for neuropsychiatric and neurological disorders that utilizes a novel mode of action to restore the healthy balance of specific neurotransmitters in the brain. These treatments represent a new class of small molecules that act as selective inhibitors (SERIs) with the potential of delivering meaningful clinical benefit to patients suffering from neuropsychiatric and neurological disorders.

ABS Biotechnologies provides a cell-based platform transforming drug toxicology and development. Using iPSC-derived vascular and cardiac cells, we deliver physiologically relevant, human-based assays that improve predictability and reduce drug failure. Our automated, imaging-enabled system provides real-time insights and customizable screening solutions. By streamlining workflows, we help biotech and pharma partners accelerate drug development and improve clinical outcomes.

Endometriosis affects 1 in 10 women, yet diagnosis still takes 7–10 years on average and often requires surgery. Diamens is developing a non-invasive menstrual blood test using validated biomarkers and scalable qPCR technology to enable earlier diagnosis, reduce suffering, and help preserve fertility. Samples can be collected at home or by a gynecologist
and analyzed through partner laboratories, providing results within days.

The white cane is a reliable companion to blind people worldwide, but there are still many obstacles it misses. Sixth Sense is a wearable designed to detect obstacles in your way, while keeping you on your path. The wearable sits on your shoulders, mimicking over-ear headphones, and connects with your phone to keep your hands free while guiding you to where you want to go. The navigation app can be used for route planning, with or without the wearable.

KinCon biolabs leverages a patented live-cell reporter platform to systematically translate protein conformational dynamics into the systematic discovery of highly efficient drug candidates. Bypassing the limits of basic target engagement assays, our unique technology delivers real-time functional readouts in living cells to decisively identify premier molecular glues, allosteric modulators, and candidates for hard-to-target proteins such as p53.

Nuvonis offers GMP-grade and fully characterized cell substrates for biopharmaceutical manufacturing, including vaccines and other advanced products, as well as cellular agriculture and cultivated meat. Our expertise covers cell line development and characterization, virus strain generation, and tailored process development solutions. We
also offer specialized manufacturing support and expert regulatory consulting to guide your projects from concept to approval.

Neuroinflammation is a key driver in neurodegenerative diseases like Alzheimer’s disease. Understanding neuroinflammation is key to develop better treatments that act
before cognitive symptoms occur. Until now, we have been lacking good tools to do that. Thyra Imaging has developed the first non-invasive technology to assess neuroinflammation through high-resolution imaging of microglia immune cells in the retina, which is known to mirror brain health.

Luminous Labs develops photobiomodulation devices and protocol software for female longevity. Our platform combines red and near-infrared light hardware, CellLight™ spectral technology and OptimalDose™ dosing logic to support wellness, reproductive-aging research and premium B2B longevity experiences across clinics, spas and health spaces.

SnoreFree is a CE-labeled, MDR-compliant medical app treating snoring & obstructive sleep apnea via oral muscle training. Our unique and science-driven therapy approach can help up
to 80% of our users to improve their sleep & life quality within just a few weeks. A clinical trial with 180 OSA patients shows significant improvements in daytime sleepiness,
sleep quality & sleep-related depression. We’ve submitted a DiGA application for prescription reimbursement in Germany.